Elvax 40P implants: sustained, local release of bioactive molecules influencing mammary ductal development.
D000818:Animals; D003900:Desoxycorticosterone / Q000008:administration & dosage*; D004343:Drug Implants; D005260:Female; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage*; D007700:Kinetics; D008321:Mammary Glands, Animal / Q000033:anatomy & histology / Q000187:drug effects / Q000254:growth & development*; D051379:Mice; D011145:Polyvinyls
D004343:Drug Implants; D011145:Polyvinyls; C016438:ethylenevinylacetate copolymer; D003900:Desoxycorticosterone; D006821:Hyaluronoglucosaminidase